Clinical Trials Browser

Phase 1 × Has results × Solid Tumors × Clear all

NCT02597036 2025-10-23

A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors

Phase 1 Terminated

62 enrolled 25 charts

Other solid neoplasm

Solid Tumors

NCT05976334 2025-10-06

An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors

Phase 1 Terminated

3 enrolled 19 charts

Other solid neoplasm

Solid Tumors

NCT04642365 2025-05-21

A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.

Phase 1 Terminated

49 enrolled 31 charts

Other solid neoplasm

Solid Tumors

NCT02699515 2024-11-18

MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors

Phase 1 Completed

114 enrolled 29 charts

Other solid neoplasm

Solid Tumors

NCT01127178 2024-10-10

Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors

Phase 1 Terminated

12 enrolled 13 charts

Other solid neoplasm

Solid Tumors

NCT01286467 2024-03-06

A Study Of PF-04449913 Administered Alone In Select Solid Tumors

Phase 1 Completed

23 enrolled 26 charts

Other solid neoplasm

Solid Tumors

NCT03225105 2023-11-22

M3541 in Combination With Radiotherapy in Solid Tumors

Phase 1 Terminated

15 enrolled 18 charts

Other solid neoplasm

Solid Tumors

NCT00648648 2023-09-21

MK-1775-001

Phase 1 Completed

206 enrolled 40 charts

Other solid neoplasm

Solid Tumors

NCT02660034 2021-12-06

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

Phase 1 Completed

229 enrolled 46 charts

Other solid neoplasm

Solid Tumors

NCT02533674 2021-06-11

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

Phase 1 Completed

57 enrolled 19 charts

Other solid neoplasm

Solid Tumors

NCT03539484 2020-09-03

A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors

Phase 1 Terminated

26 enrolled 30 charts

Other solid neoplasm

Solid Tumors

NCT01862328 2020-06-22

Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors

Phase 1 Completed

64 enrolled 21 charts

Other solid neoplasm

Solid Tumors

NCT01341457 2019-03-01

A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors

Phase 1 Completed

17 enrolled 16 charts

Other solid neoplasm

Solid Tumors

NCT01431534 2019-03-01

MK-8669-056

Phase 1 Terminated

20 enrolled 10 charts

Other solid neoplasm

Solid Tumors

NCT01214668 2019-01-04

Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors

Phase 1 Completed

31 enrolled 17 charts

Other solid neoplasm

Solid Tumors

NCT01463696 2018-08-27

Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)

Phase 1 Terminated

48 enrolled 17 charts

Other solid neoplasm

Solid Tumors

NCT01955473 2017-08-23

Japanese Phase 1 Trial of Sym004 in Solid Tumors

Phase 1 Completed

51 enrolled 49 charts

Other solid neoplasm

Solid Tumors

NCT02063230 2016-07-21

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects

Phase 1 Completed

32 enrolled 12 charts

Other solid neoplasm

Solid Tumors

NCT00658658 2016-05-18

Panitumumab in Children With Solid Tumors

Phase 1 Completed

31 enrolled 19 charts

Other solid neoplasm

Solid Tumors

NCT00424632 2012-06-25

Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors

Phase 1 Completed

57 enrolled 12 charts

Other solid neoplasm

Solid Tumors